AnalysisSouth Korea

Korean cobot makers vs China in 2026: Doosan Robotics, Neuromeka and HD Hyundai Robotics compared with FAIR, Dobot and Universal Robots

Published 4 min read
Source
AnalysisDoosan Robotics

Korea's collaborative-robot makers are turning their arms into humanoid-ready platforms mostly with government R&D money, while Chinese rivals do it with private capital and volume. On disclosed figures, Doosan Robotics' 2025 revenue fell 29.6% to KRW 32.98bn while Dobot's rose 31.7% to RMB 492.2m, and FAIR Innovation, which has just raised nearly RMB 1bn, expects 18,000 robot orders in 2026.

Government funds cover 69% of Doosan's KRW 98.9bn and 60% of Neuromeka's KRW 17.5bn physical-AI projects.

Korea's cobot makers are betting on the same idea as their Chinese rivals, that the collaborative arm becomes the arm and hand of an industrial humanoid, but they are paying for it differently. Doosan Robotics and Neuromeka are funding the shift largely through national physical-AI projects, and HD Hyundai Robotics through its group's balance sheet. Chinese makers such as FAIR Innovation and Dobot are funding it through private rounds, Hong Kong listings and unit volume. On every growth number MEKAWIRE has verified for 2025 and 2026, the Chinese side is ahead.

This piece compares what each company has disclosed, explains why the cobot is turning into a humanoid component, and sets out what would change the picture for Korea.

The numbers: growth in China, shrinkage in Korea

Doosan Robotics, Korea's largest listed cobot maker, reported 2025 consolidated revenue of KRW 32.98bn, down 29.6%, and an operating loss of KRW 59.47bn, according to its DART filings. Sales of its core cobot arms roughly halved as North American demand fell about 50% under tariff uncertainty. Dobot, listed in Hong Kong, grew 2025 revenue 31.7% to RMB 492.2m, with embodied-AI robots rising to RMB 20.0m from RMB 3.9m. Teradyne Robotics, the owner of Universal Robots and MiR, reported $100m of second-quarter 2026 revenue against $75m a year earlier.

FAIR Innovation (FAIRINO), a Suzhou-area cobot maker, has just closed Series C+ and D rounds totalling nearly RMB 1bn led by Meituan Longzhu and Meituan, according to reports by 36Kr and IPO Zaozhidao that the company has not confirmed on its site. It expects 18,000 robot orders in 2026, up 68%, which implies about 10,700 units in 2025.

Cobot makers: disclosed scale and growth
  • Doosan Robotics
    Country
    KR
    Figure
    Revenue KRW 32.98bn
    Change
    -29.6%
    Period
    FY2025
    Source type
    DART filing
  • Dobot
    Country
    CN
    Figure
    Revenue RMB 492.2m
    Change
    +31.7%
    Period
    FY2025
    Source type
    HKEX results
  • Teradyne Robotics (UR, MiR)
    Country
    US/DK
    Figure
    Revenue $100m
    Change
    +33% vs $75m
    Period
    Q2 2026
    Source type
    Company results
  • FAIR Innovation
    Country
    CN
    Figure
    18,000 units ordered (expected)
    Change
    +68%
    Period
    2026
    Source type
    Outlet report, unconfirmed

Disclosed figures only; currencies not converted. Teradyne change computed as 100/75 - 1.

As of Oct 17, 2026

Derived metrics: Doosan's 2025 operating loss equalled 180% of its revenue (59.47 divided by 32.98). Government funding is 68.9% of the KRW 98.9bn budget of Doosan's two new projects (68.1 divided by 98.9) and 60% of Neuromeka's KRW 17.5bn welding project (10.5 divided by 17.5). FAIR's implied 2025 volume is 18,000 divided by 1.68.

What each Korean maker is building

Doosan Robotics won two MOTIR and KEIT projects on Oct 6: a 54-month programme to put a Korean AI system-on-chip into three cobots with 5, 10 and 20 kg payloads and a two-armed omnidirectional industrial humanoid, aiming for standard products from 2031 with partners including AIDIN Robotics, Mobilint, KETI and KITECH; and a 45-month nuclear-component welding project with DEEPX and Doosan Enerbility. It named Kwon Young-min, previously head of Doosan Mottrol, as chief executive on Oct 1.

Neuromeka (KOSDAQ: 348340) leads a KRW 17.5bn MSIT project from August 2026 to December 2030 to train a large action model for autonomous welding of curved ship-hull blocks. It also supplies AI cobots for DIC's gear-machining line and signed a smart-building MOU with Samsung C&T, and with KAIST it showed its EIR humanoid doing two-handed work with a single head camera.

HD Hyundai Robotics launched the HDC series in July with 25, 35 and 50 kg payloads, top speed 5.9 m/s and radar-based collision avoidance, aiming at palletising and heavy handling in car, battery and logistics plants where cobots have seen little use.

Korean cobot makers: 2026 moves in MEKAWIRE records
  • Doosan Robotics
    Move
    Two national projects: on-device-AI cobots (5/10/20 kg) and humanoid; nuclear welding
    Size
    KRW 98.9bn R&D budget
    Government share
    KRW 68.1bn (68.9%)
    Date
    2026-10-06
  • Neuromeka
    Move
    MSIT large-action-model shipbuilding welding project
    Size
    KRW 17.5bn
    Government share
    KRW 10.5bn (60%)
    Date
    2026-09-28
  • HD Hyundai Robotics
    Move
    HDC cobots 25/35/50 kg with radar safety
    Size
    n/a
    Government share
    n/a
    Date
    2026-07-01
  • Doosan Robotics
    Move
    Capital injection into Doosan Robotics Americas
    Size
    $16.0m
    Government share
    n/a
    Date
    2026-03-26

From company releases and DART filings stored in MEKAWIRE. Government share = government funding divided by total project budget.

As of Oct 17, 2026

MEKAWIRE analysis: Korea is buying time with public money

Korea's cobot makers are using state R&D to buy time for a humanoid transition that Chinese rivals are financing with customers and private capital, and the gap will show in volumes before 2031.

The evidence is in the structure of the money. Doosan's humanoid-ready cobot line targets standard products from 2031; FAIR already sells ART humanoid force-control arms and says it has agreements for 4,000 of them. Chinese makers also own more of their bill of materials: FAIR says it makes its own controllers, servo drives and harmonic reducers. MEKAWIRE's Oct 16 comparison of Korean parts makers found Korea localising hands and sensors first while reducers stay import-dependent.

The strongest counter-argument is protection. Universal Robots' parent has gone to court in Germany against Elite Robots (settled on Oct 1) and JAKA this year, and US scrutiny of Chinese-made robots is rising. If Western buyers start to avoid Chinese arms, Korean makers with high-payload products such as HD Hyundai's HDC and US assembly through Doosan Robotics Americas could win share without matching Chinese prices.

Bull case: the national projects deliver certified, on-device-AI cobots ahead of 2031, Doosan's US unit converts its $14.9m backlog and HDC finds heavy-payload niches. Bear case: Chinese makers keep growing 30 to 70% a year, fund humanoid arms from volume and reach Korean customers first.

Signals to watch

Doosan Robotics' 2026 results in early 2027 and whether cobot sales recover; a company confirmation or IPO filing from FAIR Innovation; and the first public milestone of Doosan's on-device-AI cobot project, including the planned 72-hour non-stop trials at two or more sites.

Good or bad news for the company?

 

Key facts
Answer
Korean cobot makers fund the humanoid transition mainly with state R&D; Chinese rivals with private capital and volume
Dobot FY2025
Revenue RMB 492.2m (+31.7%)
Doosan projects
KRW 98.9bn, 68.9% government-funded, standard products from 2031
FAIR Innovation
Nearly RMB 1bn Series C+ and D (reported); 18,000 units expected in 2026
Neuromeka project
KRW 17.5bn, 60% government-funded, to 2030
HD Hyundai Robotics
HDC cobots 25 to 50 kg, 5.9 m/s, radar collision avoidance
Doosan Robotics FY2025
Revenue KRW 32.98bn (-29.6%), operating loss KRW 59.47bn
Sources